The Novel Drug Delivery Systems In The Cancer Therapy Market are predicted to account for US$ 88.5 billion in 2032, up from US$ 14.8 billion in 2022, advancing at a CAGR of 19.6% during the forecast period (2022-2032). Demand for novel drug delivery systems in cancer therapy is being driven by rising cancer awareness and prevalence around …